Wave Life Sciences Ltd
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.6% | -0.2% | -0.2% | -0.6% | -0.1% | +0.4% | +1.5% | +1.5% | +1.4% | -35.3% | +3.2% | – | |
| – | +3.0% | +22.5% | +21.0% | +1.3% | -8.1% | +52.7% | +25.1% | +4.5% | -372.3% | – | +18.4% | – | |
| – | – | – | – | – | -914.5% | – | – | – | +2,008.0% | -539.4% | – | – | |
| – | +79.8% | +17.1% | -87.5% | +636.5% | -77.5% | +91.9% | +85.5% | -19.0% | -96.0% | +4,276.1% | +101.8% | – | |
| – | +79.8% | +17.1% | -87.5% | +636.5% | -77.5% | +91.9% | +85.5% | -19.0% | – | -4,474.8% | +28,085.8% | – | |
| – | +5,526.5% | -84.6% | -95.5% | +31,101.5% | -82.8% | -88.1% | +181.4% | +179.6% | +1,253.9% | -99.4% | -186.9% | – | |
| – | – | -132.1% | – | – | -105.6% | – | – | – | – | -114.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.